This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings: Archive
Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
HRTXPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Toyota Motor (TM) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Toyota Motor (TM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
TMNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
M/A-Com (MTSI) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for M/A-Com (MTSI) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MTSIPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Epam (EPAM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Epam (EPAM) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
EPAMNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Epam (EPAM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Epam (EPAM) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
EPAMNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Aspen Aerogels (ASPN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Aspen Aerogels (ASPN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ASPNPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
AMC Networks (AMCX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for AMC Networks (AMCX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AMCXNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Under Armour (UAA) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Under Armour (UAA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
UAANegative Net Change
earnings earnings-estimates-revisions earnings-surprise
TSS Posts Flat Y/Y Q2 Earnings, Raises Guidance on AI Growth
by Zacks Equity Research
After Q2 results, TSSI shares fall 23.7% as revenues jump 262% and EPS remains flat. Mix pressures margins, but management raises the 2025 EBITDA guidance on AI demand.
TSSIPositive Net Change
earnings industrial-products
Natural Resource Partners Q2 Earnings Dip Y/Y on Weaker Coal, Soda Ash
by Zacks Equity Research
NRP Q2 earnings drop on lower coal and soda ash prices, but strong cash flow keeps debt paydown and higher 2026 payouts on track.
NRPPositive Net Change
earnings oil-energy
GILD Stock Rises on Q2 Earnings and Sales Beat, '25 View Up
by Zacks Equity Research
GILD tops Q2 earnings, raises 2025 guidance as HIV drugs Biktarvy and Descovy drive revenue growth.
GSKPositive Net Change GILDPositive Net Change KYMRPositive Net Change
biotechnology biotechs earnings medical pharmaceuticals
PRA Group Q2 Earnings Beat Estimates on Rising Cash Collections
by Zacks Equity Research
PRAA's Q2 earnings beat estimates by 74.2% as rising U.S. and European cash collections boost results.
PRAANegative Net Change LAZPositive Net Change EVRPositive Net Change AAMIPositive Net Change
earnings finance
Main Street Capital Q2 Earnings Meet Estimates, Expenses Rise Y/Y
by Zacks Equity Research
MAIN's Q2 adjusted net investment income meets estimates as rising expenses offset higher total income.
ARCCPositive Net Change HTGCPositive Net Change MAINPositive Net Change
earnings finance
Exploring Analyst Estimates for Red Robin (RRGB) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Red Robin (RRGB), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
RRGBPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exploring Analyst Estimates for Kamada (KMDA) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Kamada (KMDA) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
KMDANegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unlocking Q4 Potential of Coherent (COHR): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Coherent (COHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
COHRPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
What Analyst Projections for Key Metrics Reveal About Cisco (CSCO) Q4 Earnings
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Cisco (CSCO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.
CSCOPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Countdown to Bally's (BALY) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Bally's (BALY) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
BALYPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Ahead of CAE (CAE) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of CAE (CAE) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CAEPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Wall Street's Insights Into Key Metrics Ahead of Fidelis Insurance (FIHL) Q2 Earnings
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Fidelis Insurance (FIHL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
FIHLNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Countdown to Brinker International (EAT) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Brinker International (EAT) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
EATPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
American Axle & Manufacturing (AXL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
American Axle (AXL) delivered earnings and revenue surprises of +61.54% and +2.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AXLPositive Net Change INVZPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Stay Ahead of the Game With European Wax Center (EWCZ) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of European Wax Center (EWCZ) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
EWCZPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Seeking Clues to Globale Online (GLBE) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Globale Online (GLBE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
GLBENegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Wall Street's Insights Into Key Metrics Ahead of MSG Entertainment (MSGE) Q4 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of MSG Entertainment (MSGE) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
MSGEPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview